Questions? +49 (0)89 660 680

Communications

Communications

Welcome to the RINECKER PROTON THERAPY CENTER (RPTC) in Munich!

The RPTC is the first European proton radiation center that provides a complete hospital setting for the treatment of cancer. Proton therapy is the logical next step in radiation therapy. This innovative therapeutic procedure uses high-energy proton beams to treat cancer. Unlike X-rays used in conventional radiation therapy, protons allow three-dimensional targeting of the tumor. This allows highly effective doses to be delivered to the tumor while minimizing trauma to the surrounding healthy tissue and thus minimizing the side effects typically associated with radiation treatment.

The Center’s five treatment units provide facilities for up to 4,000 patients insured under social-insurance schemes and for private patients. The partner hospital is the Chirurgische Klinikum München Süd

Thank you for your interest in our site.

Façade of the RPTC in Munich

Construction of the facilities where cancer patients are treated along with the attached RPTC GUEST HOUSE cost 150 million euros.

Lobby of the RINECKER PROTON THERAPY CENTER

The RPTC in Munich is the first European center expressly designed and built for patient treatment rather than as an extension of a research facility.

Treatment room with target device (gantry)

One of four identical treatment rooms at the RINECKER PROTON THERAPY CENTER (RPTC) in Munich. The gantry weighs 150 tons, has a diameter of eleven meters, and can be turned 360° in one-millimeter increments around the patient within one minute.

Treatment room with target device (gantry)

Treatment room with target device (gantry). One of four identical treatment rooms at the RPTC in Munich. The patient table can be moved in all directions. The beam can be directed with a high degree of precision with an accuracy to within less than a millimeter. For this purpose, the patient must be positioned in exactly the same way for each radiation session. For immobilization, the patient lies in the blue individually adjusted contour mattress.

Workstation for monitoring and assessing the staging examination using the positron emission tomography equipment (PET-CT)

Positron Emission Tomography (PET-CT)

In the case of suspected metastasis or tumors that frequently metastasize, such as bronchial carcinomas (lung cancer), positron emission tomography (PET) is also used at the RPTC in combination with a CT device (the combination is referred to as PET-CT). For this procedure, the patient is injected with contrast medium marked with a short-lived radioactive isotope. This enables both precise tumor localization (CT) and identification of metabolically active tumor fractions (with the isotope marking areas of increased metabolic activity in the tumor or metastasis) to be accomplished in a single session.

Radiation source (superconducting cyclotron; 250 MeV)

In the particle accelerator, the protons are accelerated to 60% of the speed of light using electromagnetic fields. They are guided into a vacuum tube using an electric field and directed to the therapy site (gantry).

Copyright © 2018 Pro Health AG